HOPA Partners with other Oncology Leaders to Maintain IV Chemo Resources

MILWAUKEE, WI – September 3, 2021 – The Hematology/Oncology Pharmacy Association (HOPA) collaborated with National Community Oncology Dispensing Association, Inc. (NCODA), Oncology Nursing Society (ONS) and Association of Community Cancer Centers (ACCC) to launch a new Intravenous Cancer Treatment Education (IVE) website, ivcanceredsheets.com.

The website is a joint effort dedicated to forward thinking and to providing thorough education resources to improve treatment outcomes. The IVE website provides healthcare workers the latest education material for intravenous cancer treatments, communicating vital information to help caregivers and those experiencing cancer.

The sheets include common uses and treatment schedules, supportive medications, drug interactions, side effect management and safe handling tips at home following treatment.

Oncology professionals and caregivers can download a number of IVE sheets from the site’s library, which will continue to be updated by the collaborative. The sheets also are editable so pharmacists can customize them to an individual’s treatment plan.

The launch of IV Cancer Treatment Education Sheets online follows the success of the highly utilized OCE (Oral Chemotherapy Education) online resource, which also is a collaborative initiative between NCODA, HOPA, ONS and ACCC. With a committee consisting of representatives from each of the organizations, a development process is structured to produce trusted and reliable education sheets that provide a robust amount of information on individual drugs and combination drug regimens.

The Hematology/Oncology Pharmacy Association (HOPA) supports hematology/oncology pharmacy professionals and promotes the role of the pharmacist in collaborative cancer care. Founded in 2004, HOPA provides crucial education, networking, and advancement opportunities frequently sought by pharmacists, pharmacy interns, residents, fellows, students, technicians, researchers, and administrators who specialize in hematology/oncology pharmacy. Its vision is to ensure that all individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team

Image of stem cell treatment
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Axatilimab-csfr

Sydney Hunt, PharmD, PGY-1 Pharmacist Resident, and Lindsay Orton, PharmD, BCOP, Stem Cell Transplant and Cellular Therapy Clinical Pharmacist, both from Vanderbilt University Medical Center, Nashville, TN, write about axatilimab-csfr (Niktimvo).

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Afamitresgene autoleucel

Emili Anderson, PharmD, PGY1 Acute Care Resident, and Roger Ngo, PharmD Candidate, both from UNC Medical Center, Chapel Hill, NC, write about afamitresgene autoleucel (afami-cel).

digital medical illustration of lung cancer in a person's chest
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Tarlatamab-dlle

SeongEun Emily Park, PharmD PGY2-Hematology/Oncology Pharmacy Resident Emory University Hospital Midtown/Winship Cancer Institute writes about tarlatamab-dlle.